 | Related Articles |
Pharmacological treatments for smoking cessation.
JAMA. 2014 Jan 8;311(2):193-4
Authors: Cahill K, Stevens S, Lancaster T
Abstract
CLINICAL QUESTION: Among the 3 first-line smoking cessation treatments (nicotine replacement therapy [NRT], bupropion, and varenicline), which is most effective in helping people who smoke achieve and maintain abstinence from smoking for at least 6 months, and what serious adverse events are associated with each?
BOTTOM LINE: Higher rates of smoking cessation were associated with NRT (17.6%) and bupropion (19.1%) compared with placebo (10.6%). Varenicline (27.6%) and combination NRT (31.5%) (eg, patch plus inhaler) were most effective for achieving smoking cessation. None of the therapies was associated with an increased rate of serious adverse events.
PMID: 24399558 [PubMed - indexed for MEDLINE]
Read More... Read More
